Toyota|$17.87 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.03 (¥3,960)+0.03%▲ (in JPY terms)
SoftBank|$30.62 (¥4,845)-2.00%▼ (in JPY terms)
MUFG|$21.98 (¥3,478)+0.09%▲ (in JPY terms)
Keyence|$514.47 (¥81,410)+0.80%▲ (in JPY terms)
Nintendo|$53.97 (¥8,541)+0.73%▲ (in JPY terms)
NTT|$1.11 (¥175)+0.34%▲ (in JPY terms)
Takeda|$39.46 (¥6,244)+0.34%▲ (in JPY terms)
Tokyo Electron|$65.41 (¥10,350)-2.63%▼ (in JPY terms)
Recruit|$118.65 (¥18,775)+1.93%▲ (in JPY terms)
ITOCHU|$14.66 (¥2,320)+1.58%▲ (in JPY terms)
Honda|$11.42 (¥1,808)+0.56%▲ (in JPY terms)
Shin-Etsu|$37.70 (¥5,966)-0.20%▼ (in JPY terms)
Tokio Marine|$3.51 (¥555)-0.61%▼ (in JPY terms)
Fast Retailing|$466.70 (¥73,850)-2.29%▼ (in JPY terms)
Toyota|$17.87 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.03 (¥3,960)+0.03%▲ (in JPY terms)
SoftBank|$30.62 (¥4,845)-2.00%▼ (in JPY terms)
MUFG|$21.98 (¥3,478)+0.09%▲ (in JPY terms)
Keyence|$514.47 (¥81,410)+0.80%▲ (in JPY terms)
Nintendo|$53.97 (¥8,541)+0.73%▲ (in JPY terms)
NTT|$1.11 (¥175)+0.34%▲ (in JPY terms)
Takeda|$39.46 (¥6,244)+0.34%▲ (in JPY terms)
Tokyo Electron|$65.41 (¥10,350)-2.63%▼ (in JPY terms)
Recruit|$118.65 (¥18,775)+1.93%▲ (in JPY terms)
ITOCHU|$14.66 (¥2,320)+1.58%▲ (in JPY terms)
Honda|$11.42 (¥1,808)+0.56%▲ (in JPY terms)
Shin-Etsu|$37.70 (¥5,966)-0.20%▼ (in JPY terms)
Tokio Marine|$3.51 (¥555)-0.61%▼ (in JPY terms)
Fast Retailing|$466.70 (¥73,850)-2.29%▼ (in JPY terms)

2026-09-03 Eisai Co.,Ltd. “Rekenbi®, a subcutaneous injection formulation, has received approval in China as an initial treatment for early-stage Alzheimer's disease—the first and only home-administered anti-amyloid therapy for Alzheimer's disease, a progressive neurodegenerative disease, in China.”

2026-09-03 Eisai Co.,Ltd. “Rekenbi®, a subcutaneous injection formulation, has received approval in China as an initial treatment for early-stage Alzheimer's disease—the first and only home-administered anti-amyloid therapy for Alzheimer's disease, a progressive neurodegenerative disease, in China.”

コメントする